Engene Therapeutics Inc(ENGN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Engene Therapeutics Inc

4868 RUE LEVY SUITE 220
SAINT-LAURENT A8 H4R 2P1 CAN
P: 514-332-4888
https://engene.com

Profile

enGene Holdings Inc. is a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues. enGene Holdings Inc., formerly known as Forbion European Acquisition Corp., is based in MONTREAL.

Key Executives

NameTitle
Ryan DawsCFO/Chief Accounting Officer
Kathleen RichtonCFO/Chief Accounting Officer/Senior VP, Divisional

More from The Globe

At Telus, will the new boss deliver a new dividend policy?
Victor Dodig speaks at the Intersect 2025 conference on June 9, 2025 in Toronto.
The highest-yielding stocks on the TSX, plus risk data
The S&P TSX composite index screen at the TMX Market Centre in downtown Toronto is photographed on Friday, Nov. 11, 2022.
Two top TSX gainers this year that insiders love (and one big loser)
Ted Dixon
number cruncher
Seven airline stocks that could take flight as oil prices fall
For Number Cruncher column in Globe Investor/ROB only.
Bullish on Gibson Energy Inc.
Monica Rizk
Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
The S&P TSX composite index screen at the TMX Market Centre in downtown Toronto is photographed on Nov. 11, 2022.
Friday’s analyst upgrades and downgrades
Rock bolting on a scissor lift at Wesdome's Kiena Mine in Val d'Or, Quèbec.
Will a new pipeline reinvigorate Canadian energy stocks?
Pumpjacks pump crude oil near Halkirk, Alta., on June 20, 2007. THE CANADIAN PRESS/Larry MacDougal

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.